Detalhe da pesquisa
1.
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Blood
; 141(11): 1265-1276, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265087
2.
ULK2 Is a Key Pro-Autophagy Protein That Contributes to the High Chemoresistance and Disease Relapse in FLT3-Mutated Acute Myeloid Leukemia.
Int J Mol Sci
; 25(1)2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203816
3.
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
Int J Mol Sci
; 25(1)2023 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203669
4.
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.
Blood
; 136(6): 674-683, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285126
5.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Blood
; 135(5): 371-380, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826241
6.
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
Br J Haematol
; 191(5): 748-754, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32395867
7.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med
; 377(5): 454-464, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28644114
8.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Nature
; 506(7488): 328-33, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24522528
9.
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.
Blood
; 140(3): 285-289, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507690
10.
A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy.
Support Care Cancer
; 27(6): 2295-2300, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341536
11.
Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysis.
Hematol Oncol
; 35(4): 810-813, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27597292
12.
Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts.
Biol Blood Marrow Transplant
; 22(5): 815-24, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26779931
13.
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.
Blood
; 124(9): 1426-33, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006120
14.
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.
Invest New Drugs
; 34(5): 614-24, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406088
15.
Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters.
Ann Hematol
; 95(12): 2057-2064, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542955
16.
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.
Eur J Haematol
; 97(5): 471-478, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028202
17.
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Am J Hematol
; 96(5): E175-E179, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617672
18.
An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia.
Am J Hematol
; 96(1): E17-E20, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021743
19.
Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy.
Biol Blood Marrow Transplant
; 21(3): 559-64, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536215
20.
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
Br J Haematol
; 168(3): 384-94, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25303497